Predictive value of interleukin-17A in the early diagnosis and prognosis of adult sepsis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300078235

Enrollment

Unknown

Registered

2023-12-01

Start date

2023-12-01

Completion date

Unknown

Last updated

2023-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Research group (sepsis group):Observational studies without intervention measures

Control group (non sepsis group):Observational studies without intervention measures

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: ? Age = 18 years old, acute onset time = 48 hours; ? Hospitalized patients with community acquired infections ? meet the diagnostic criteria for sepsis or septic shock; ? Recommended comprehensive treatment according to guidelines; ? The patient or their authorized family member signs an informed consent form, and the clinical data is complete.

Exclusion criteria

Exclusion criteria: ? Individuals under the age of 18 have an acute onset time greater than 48 hours; ? Merging malignant tumors; ? Autoimmune diseases; ? Recently undergoing major surgery; ? Patients with mental illness or inability to cooperate with treatment; ? Severe malnutrition. ? Give up treatment midway.

Design outcomes

Primary

Measure	Time frame
Interleukin-17A ;Procalcitonin;Interleukin-6;Arterial blood lactate;ROC curve;AUC;	—

Countries

China

Contacts

Public ContactJinyuan Chen

Jiangmen Xinhui People's Hospital

redredncbi@163.com+86 181 2828 1281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026